ReCor is bringing some of that momentum it had in 2022 over into 2023 with the announcement of a new CEO. Lara Barghout is taking the helm of the Palo Alto, CA-based company, which is currently one of the few firms generating strong data that is keeping the dream of fighting hypertension with renal denervation alive.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,